SCHEMBL21165324

SCHEMBL21165324

CC(C)C(C)(c1cnc2ccc(Cl)cc2n1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR3 P22607 1/20 0.41
▸ KDR P35968 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 2/20 0.39
▸ CYP3A4 P08684 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ GMNN O75496 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ APEX1 P27695 1/20 0.39
▸ PMP22 Q01453 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ HRH4 Q9H3N8 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18464468 1.00 FGFR3 (0.41) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL18463970 0.82 KDM4E (0.36) CYP3A4KDM4EKMT2APDGFRBPDGFRA
SCHEMBL18463972 0.81 FGFR3 (0.44) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL18463934 0.77 KDM4E (0.36) CYP3A4KDM4EKMT2APDGFRBPDGFRA
SCHEMBL18463780 0.75 HRH4 (0.46) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL10220436 0.74 HRH4 (0.48) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL30889393 0.73 FGFR3 (0.46) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL15221559 0.73 FGFR3 (0.48) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL23651806 0.69 FGFR3 (0.46) FGFR3KDRALDH1A1MAPTCYP3A4
SCHEMBL14843746 0.69 FGFR3 (0.54) FGFR3KDRALDH1A1MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10351527-B2 Binding function 3 (BF3) site compounds as therapeutics and methods for their use THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2019-07-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351527-B2 Binding function 3 (BF3) site compounds as therapeutics and methods for their use KLK3, SHBG, ACP3 FGFR3 34/4885KDR 902/4885ALDH1A1 2387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback